Valiant Laboratories Shares Price Rise 4.12% After Subsidiary Begins Operations at New Gujarat Facility

Mumbai, November 7, 2025: The share price of Valiant Laboratories Ltd closed at ₹84.50 on Friday, up 4.12% on the NSE, following the company’s announcement that its wholly owned subsidiary has begun operations at a new state-of-the-art facility in Saykha GIDC, Bharuch.

The company emphasizes the new state-of-the-art plant at Saykha GIDC, Bharuch, which records a significant milestone in its strategic growth roadmap. This move is aimed at strengthening backward integration, diversifying its product portfolio, and entering the specialty chemicals segment.

Facility Highlights

The Saykha facility is equipped with advanced manufacturing technology and a dedicated R&D unit. The unit is built on the basis of a substantial investment funded partly through IPO proceeds. Acetic Anhydride, a key Ketene and Diketene derivative which is primarily used across domestic and export markets, will be produced in this state-of-the-art facility.

Share Price Update

On Friday, Valiant shares opened at ₹81.49, touched a high of ₹84.90, and a low of ₹80.05. The company’s market capitalization currently stands at ₹459 crore. Over the past year, the stock has declined 21%, with a 7.85% drop over the last six months and 3.59% in the past month.

REF: https://nsearchives.nseindia.com/corporate/VALIANT_07112025124516_Press_Release_Saykha_plant_VASPL.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations